Searchable abstracts of presentations at key conferences in endocrinology

ea0016p289 | Endocrine tumours | ECE2008

Cytoplasmic shift of AUF1 in thyroid carcinoma

Trojanowicz Bogusz , Brodauf Lars , Sekulla Carsten , Chen Zhouxun , Bialek Joanna , Radestock Yvonne , Hombach-Klonisch Sabine , Klonisch Thomas , Finke Rainer , Dralle Henning , Hoang-Vu Cuong

AUF1/heterogeneous nuclear ribonucleoprotein D (hnRNPD) is an adenylate uridylate-rich elements (ARE) binding protein, which regulates the mRNA stability of many genes related to growth regulation, such as proto-oncogenes, growth factors, cytokines and cell cycle regulatory genes. Several studies demonstrated AUF1 expression in kidneys, liver, lymphoid tissues and melanocytes, and its involvement in apoptosis, tumorigenesis and development by its interactions with AREs bearing...

ea0011p407 | Diabetes, metabolism and cardiovascular | ECE2006

Urocortin 2 mediates glucose utilization and insulin sensitivity in skeletal muscle

Chen A , Brar B , Choi CS , Rousso D , Vaughan J , Donaldson C , Smith S , Li C , Kim SN , Nagy T , Shulman G , Lee KF , Vale W

Skeletal muscle is the principal tissue responsible for insulin-stimulated glucose disposal and is thus the major site of peripheral insulin resistance. Urocortin 2 (Ucn2), a corticotropin releasing factor (CRF) family member and the type 2 CRF receptor (CRFR2) are highly expressed in skeletal muscle. To determine the physiological role of Ucn2, we generated mice deficient in this peptide. Using glucose and insulin tolerance tests and hyperinsulinemic euglycemic glucose clamp ...

ea0056oc3.4 | New insights in bone disorders | ECE2018

Renal function change in chronic hypoparathyroidism patients treated with recombinant human parathyroid hormone (1-84) (rhPTH[1-84]) and in a historical control cohort treated with standard therapy

Chen Kristina , Rubin Mishaela , Mu Fan , Swallow Elyse , Zhao Jing , Wang Jessie , Krasner Alan , Sherry Nicole , Signorovitch James , Ketteler Markus , Bilezikian John

Standard therapy (ST) for chronic hypoparathyroidism (HPT) includes calcium and active vitamin D supplementation, which can be associated with an increased risk of renal complications. This study compared renal function change, assessed by estimated glomerular filtration rate (eGFR) over 5 years between HPT patients receiving rhPTH1-84 as an adjunct to ST and a historical control cohort without rhPTH1-84. rhPTH1-84-treated HPT patients were selected from two single-arm, long-t...

ea0056p241 | Calcium & Vitamin D metabolism | ECE2018

Burden of illness among patients with chronic hypoparathyroidism not adequately controlled with standard therapy by self-perception

Siggelkow Heide , Clarke Bart L. , Dahl-Hansen Helen , Glenister Elizabeth , Judge Davneet , Bent-Ennakhil Nawal , Gibson Katie , Germak John , Chen Kristina , Marelli Claudio , Bollerslev Jens

Significant knowledge gaps exist regarding the humanistic effects of chronic hypoparathyroidism (HPT), a rare, debilitating condition. We provide interim results from a global survey conducted to characterise the burden associated with chronic HPT from the patient perspective. An anonymous, self-reported survey (online or paper) was conducted in patients with chronic HPT, not adequately controlled with standard therapy by self-perception, from 12 countries through physicians o...

ea0073oc3.6 | Oral Communications 3: Pituitary and Neuroendocrinology | ECE2021

Expression and possible role of integrins in corticotroph tumours

Chen Xiao , Simon Julia , Luis Perez-Rivas , Jörg Flitsch , Honegger Jürgen , Rachinger Walter , Stalla Günter , Reincke Martin , Theodoropoulou Marily

IntroductionIntegrins are heterodimeric transmembrane proteins composed of alpha and beta subunits that mediate cell-cell and cell-extracellular matrix (ECM) interactions. Several integrins are overexpressed in human cancers and their ECM recognition motif, arginine-glycine-aspartate (RGD), is being utilized for tumour imaging and targeting.AimTo explore the expression and function of RGD-binding integrins in...

ea0094p139 | Thyroid | SFEBES2023

Iodine concentration and palatability of milk from cows fed the common red seaweed species Himanthalia elongata

Kayes Lucy , Mullan Karen , Barnes Kayley , Armaforte Emanuele , Chen Xianjiang , Yan Tianhai , Newton Eric , Stergiadis Sokratis , Hayes Maria , Huws Sharon , Woodside Jayne , Theodoridou Katerina

Cow’s milk remains a key source of iodine in the UK. However, there are concerns around the environmental impact of methane emissions from dairy cattle. Initial work suggests that adding certain seaweed species to the diet of cows can reduce enteric methane emissions and may increase the content of certain minerals such as iodine in milk. Little is known about the simultaneous effect of this feeding practice on milk organoleptic characteristics. This study investigates th...

ea0098c23 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging | NANETS2023

Phase 1/2 study of Lu-177-DOTATATE in combination with olaparib in metastatic or inoperable GI neuroendocrine tumors - first results

Lin Frank I. , Del Rivero Jaydira , Carrasquillo Jorge , Shamis Inna , Zou Joy , Turkbey Baris , Klubo Joanna , Mena Esther , Lindenberg Liza , Chen Clara , Herscovitch Peter , Millo Corina , Pacak Karel

Background: GI neuroendocrine tumors express somatostatin (SSTR) receptors, and the radioloabeled SSTR analog Lu-177-DOTATATE is an FDA-approved systemic treatment for those with metastatic disease. Olaparib is a poly (ADP-ribose) polymerase inhibitor (PARPi) which inhibits cells from repairing damaged DNA, especially single-stranded DNA breaks caused by beta particle emissions from the radioactive decay of Lu-177. We report the first results of a phase 1/2 study evaluating th...

ea0098t3 | Trials In Progress | NANETS2023

Phase 1/2 trial of Pb-212-VMT-alpha-NET in GI neuroendocrine tumors and pheochromocytoma/paraganglioma previously treated with radioligand therapy

Lin Frank I. , Del Rivero Jaydira , Carrasquillo Jorge , Shamis Inna , Zou Joy , Turkbey Baris , Klubo Joanna , Mena Esther , Lindenberg Liza , Chen Clara , Herscovitch Peter , Millo Corina , Pacak Karel

Background: Metastatic GI Neuroendocrine Tumors (GI-NET) and pheochromocytoma/paraganglioma (PPGL) are are tumors which overexpresses somatostatin receptors (SSTR) and can be treated with targeted radioligand therapy (RLT) such as Lu-177-DOTATATE. However, despite demonstrated clinical efficacy at stabilizing tumor growth, durable response is very rare and almost all patients inevitably progresses at some time after treatment. Good systemic therapy options after beta-emiting R...

ea0089c27 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging | NANETS2022

Performance of 68Ga-DOTATATE PET/CT, 18F-FDG PET/CT, CT, and MRI Spine in the Detection of Spinal Bone Metastases in Metastatic Pheochromocytoma/Paraganglioma

Jha Abhishek , Patel Mayank , Saboury Babak , Millo Corina , Ling Alexander , Shah Ritu , Chen Clara C. , Meuter Leah , Talvacchio Sara , Knue Marianne , Lin Frank I. , O'Sullivan Coyne Geraldine , Chen Alice P. , Nilubol Naris , Herscovitch Peter , Taieb David , Cahid Civelek Ali , Carrasquillo Jorge A. , Pacak Karel

Background: To evaluate and compare the diagnostic performance of 68Ga-DOTATATE PET/CT to 18F-FDG PET/CT, CT of neck, chest, abdomen and pelvis (CT), and MRI of cervical, thoracic, and lumbar spine (MRI spine), for the detection of spinal bone metastases in metastatic pheochromocytoma and/or paraganglioma (PPGL).Methods: Between 2014 and 2019, 41 consecutive metastatic PPGL patients (19 females; mean age, 43 years) underwent 68...

ea0099p322 | Pituitary and Neuroendocrinology | ECE2024

Minimum data set for global monitoring of the safety and efficacy of growth hormone replacement in adults - an expert group recommendation

Ching Chen Suet , Ahmed Faisal , Andrews Deno , M.K. Biller Beverly , Luiz Boguszewski Cesar , Bryce Jillian , Chen Minglu , Clayton Peter , Fleseriu Maria , Gebauer Judith , Ho Ken , Otto Jorgensen Jens , Luo Xiaoping , Miller Bradley , Neggers Sebastian , Savendahl Lars , Schilbach Katharina , J. Strasburger Christian , Takahashi Yutaka , Vitali Diana , Yuen Kevin , Hoffman Andrew , Johannsson Gudmundur

Introduction: Growth hormone (GH) replacement therapy is safe and confers significant benefits in body composition, bone health, cardiometabolic risk factors, and quality of life in adults with GH deficiency. However, longer term safety and efficacy data are limited by the lack of consistency in data collection between studies. The study aim was to develop a simple global register by standardising and developing a minimum data set (MDS) to facilitate international collection o...